Navigating Breast Cancer Risk: A Practical Guide for the Family Physician

By Dr. Avinash Deo, Medical Oncologist

September 12, 2025

The Questions We Hear Every Day

A 40-year-old woman sits in your clinic and asks, “Doctor, is it time for my first mammogram?” The next patient, a 35-year-old, says, “My mother had breast cancer at 48. What should I be doing?”

These are not simple questions. In an era of conflicting headlines and widespread patient anxiety, the family physician’s role in guiding breast cancer screening has never been more crucial. The “one-size-fits-all” model of starting annual mammograms at 40 is an outdated concept. Modern, effective screening is not about a universal age; it’s about individual risk stratification.

This guide provides a clear, evidence-based framework to help you categorise your patients into distinct risk groups, allowing you to provide personalised, life-saving advice.

Category 1: The Average-Risk Woman

This group represents the majority of women in your practice.

Who She Is:

• No personal history of breast cancer.
• No strong family history (e.g., no first-degree relative with premenopausal breast cancer).
• No known high-risk genetic mutations (like BRCA1/2).
• No history of receiving chest radiation therapy before the age of 30.

Your Management Plan:

• Clinical Breast Exam (CBE): Optional, but reasonable to perform every 1-3 years for women 25-39, then annually from 40 onwards.
• Mammogram: The cornerstone of screening. Begin annually for women at age 40.

Clinical Pearl: For the average-risk woman, your role is to provide clear, evidence-based reassurance and demystify the screening process. Consistency is key.

Category 2: The Woman with Increased / Moderate Risk

This is the nuanced category where your clinical judgment and proactive management are vital.

Who She Is:

• Has a personal history of certain breast conditions like Lobular Carcinoma In Situ (LCIS) or Atypical Ductal Hyperplasia (ADH).
• Has one first-degree relative (mother, sister, daughter) diagnosed with breast cancer before age 50.
• Has multiple relatives on the same side of the family with breast cancer but no mutation increasing the risk of breast cancer found.
• Has a calculated lifetime risk of 15-20% (using models like the Tyrer-Cuzick or Gail model).

Your Management Plan:

• Clinical Breast Exam (CBE): More frequent monitoring is necessary. Perform every 6-12 months.
• Mammogram: Start annually at age 40, OR 10 years before the age of the youngest family member’s diagnosis (whichever comes first).
• Consider Supplemental Screening: For women in this group, especially those with dense breasts, a supplemental Breast MRI can be a powerful tool for detecting cancers missed by mammography.
• Discuss Risk Reduction: This is a crucial conversation. These women may be candidates for risk-reducing medications like Tamoxifen or Raloxifene.

Clinical Pearl: This is the group that benefits most from a “high-touch” approach. More frequent exams and a discussion about supplemental screening and chemoprevention can significantly alter their risk trajectory.

Category 3: The High-Risk Woman

Identifying these women is one of the most important things we can do in preventative medicine. They require a fundamentally different level of care.

Who She Is:

• Has a known mutation in a high-risk gene. While BRCA1 and BRCA2 are the most common, this also includes other significant genes like PALB2, TP53, PTEN, and CDH1.
• Has a first-degree relative with one of these known mutations.
• Received radiation therapy to the chest between the ages of 10 and 30 (e.g., for Hodgkin lymphoma).
• Has a calculated lifetime risk of >20%.

Your Management Plan:

• Clinical Breast Exam (CBE): Every 6-12 months, starting from age 25.
• Annual Breast MRI: This is the most sensitive screening tool for this group. Start at age 25.
• Annual Mammogram: Start at age 30. The MRI and mammogram are typically staggered every 6 months to provide continuous surveillance.
• Discuss Risk-Reduction Medication: Chemoprevention with agents like Tamoxifen is an important part of the conversation.
• Discuss Risk-Reducing Surgery: Prophylactic mastectomy can reduce the risk of breast cancer by over 90% in these women and should be discussed as a valid option.

Clinical Pearl: The single most important action for a high-risk patient identified in your clinic is a prompt referral to a specialised high-risk oncology clinic or a genetic counsellor. They require multidisciplinary management beyond the scope of standard primary care.

At-a-Glance Summary

Risk Category	Key Definition	Key Management Strategy
Average Risk	No major personal/family history	Annual mammogram starting at age 40.
Increased Risk	One 1st-degree relative <50, personal history (LCIS)	Annual mammogram, consider supplemental MRI, discuss risk-reduction medication.
High Risk	BRCA mutation, chest radiation <30	Annual MRI from age 25, annual mammogram from age 30, refer to specialist.

The Bottom Line

As family physicians, you are the gatekeepers of preventative health. By moving beyond a simple age-based algorithm and actively stratifying your patients’ breast cancer risk, you can provide truly personalised care. Your vigilance in identifying those with increased and high risk can make the critical difference between a late-stage diagnosis and an early, curable one.